Clinical Trials Logo

Clinical Trial Summary

Atrial Fibrillation (AF) is one of the most common postoperative complications after coronary artery bypass grafting (CABG). Postoperative AF produces a substantial impact on hospital resources with an estimated annual expenditure of over $1 billion. This includes the cost of pharmacological treatment and the cost of the increased length of stay. The incidence of AF is about 30-40% in CABG patients and increases with age of the patient. As the average age of the patient that undergoes CABG surgery is increasing, it is critical to find a way to prevent or reduce the incidence of this complication.

We propose a prospective, randomized, controlled study to determine the role of pulmonary vein isolation by bipolar ablation in the prevention or reduction of postoperative AF. The block- randomization plan will be used to maintain balance of the study and control arms throughout the study.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00765089
Study type Interventional
Source University of Pittsburgh
Contact
Status Completed
Phase Phase 4
Start date December 2005
Completion date March 2010

See also
  Status Clinical Trial Phase
Recruiting NCT03857711 - Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation) N/A
Completed NCT02132767 - Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation Phase 3
Recruiting NCT03868150 - Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment Phase 4
Completed NCT01742039 - Prevention of Postoperative Atrial Fibrillation
Recruiting NCT06151652 - Effect of Alpha-Lipoic Acid Supplementation on the Incidence of Postoperative Atrial Fibrillation in Cardiac Surgery Patients Phase 4
Recruiting NCT05076019 - Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement N/A
Completed NCT03646773 - Microvascular Effects of Intravenous Esmolol During Postoperative Atrial Fibrillation
Recruiting NCT05730413 - Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery Phase 4
Completed NCT04307225 - Atrial Fibrillation After CABG and PCI
Completed NCT05009914 - A New Way of Cardiac Denervation to Reduce the Incidence of AF After CABG. N/A
Recruiting NCT03905759 - Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG Phase 2/Phase 3
Recruiting NCT06054360 - Predictive Value of Right Atrial Strain in Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Recruiting NCT05320705 - The Effect of Intra Operative Dexmedetomidine in Prevention of Early Postoperative Atrial Fibrillation Phase 1
Recruiting NCT05062239 - Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins N/A